IJH
US Mid CapiShares Core S&P Mid-Cap ETF
iShares · Tracks S&P MidCap 400 Index · Inception May 22, 2000
Composite score
Based on a 0.050% expense ratio.
Based on $124.33B in net assets.
Top-10 holdings represent 10.4% of net assets.
US Mid Cap base · ETF wrapper · 1.17% TTM yield.
The composite is a weighted average of the four core sub-scores above (cost, tax efficiency, liquidity, concentration). Missing sub-scores fall back to the per-category median when the category has at least 50% data coverage, so funds without (e.g.) parsed N-PORT holdings aren't accidentally boosted by renormalization. Tracking quality is shown where computable but isn't currently part of the composite weighting. See methodology for formulas, the tracking-quality partial-coverage rationale, and the dimensions we deliberately don't score (methodology v0.5.1).
Use IJH in our tools
Tool · Cost
Compare IJH's fee against another fund
Compounds the 0.050% expense ratio against a peer over decades.
Tool · Overlap
Compare IJH's holdings with peers
Pairwise holdings heatmap, pre-loaded with similar US Mid Cap funds.
Tool · TLH
Find a tax-loss harvesting partner for IJH
Ranks every catalog fund by holdings overlap, flags wash-sale risk.
Tool · Placement
Where should this fund live across your accounts?
Asset-location optimizer — places each fund in taxable / tax-deferred / Roth.
Top holdings
| # | Holding | Weight |
|---|---|---|
| 1 | BLACKROCK GLOBAL | 3.68% |
| 2 | TechnipFMC PLC | 0.87% |
| 3 | Casey'S General Stores Inc. | 0.84% |
| 4 | United Therapeutics Corporation | 0.80% |
| 5 | Curtiss-Wright Corp. | 0.78% |
| 6 | FLEX LTD | 0.75% |
| 7 | XPO Inc | 0.71% |
| 8 | Woodward Inc. | 0.67% |
| 9 | Royal Gold, Inc. | 0.64% |
| 10 | US Foods Holding Corp | 0.63% |
Compare IJH with another fund
Or skim the closest-overlap funds below.
Similar ETFs by holdings overlap
Open IJH at a brokerage
Affiliate links — opening an account through these earns PlainIndex a one-time referral. Scoring is computed before any affiliate consideration; see our methodology and funding disclosure.